Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease hyperthermia
Comorbidity C0026946|fungal infection
Sentences 3
PubMedID- 22506121 We wanted to emphasize these two specific products also because they have been subject of a “pharmacoeconomic study.” as a result of the analysis, that involved the two drugs in the empirical treatment of persistently febrile neutropenic patients with presumed fungal infection, ambisome was found to be more cost-effective compared to abelcet [32].
PubMedID- 20882524 We prospectively examined the effect and safety of micafungin against febrile neutropenia with suspected fungal infection in 53 patients (median age, 56 years) who had undergone chemotherapy.
PubMedID- 19942413 Caspofungin is also licensed for empirical antifungal therapy of presumed fungal infections in patients with febrile neutropenia.

Page: 1